Referral Characteristics of Palliative Care Service in Patients With Advanced Non-Small Cell Lung Cancer in a Tertiary Cancer Center

Abstract

Background:

The American Society of Clinical Oncology recently recommends patients with metastatic non-small cell lung cancer (NSCLC) should be offered palliative care services earlier. We sought to investigate the timing of palliative care referral of Chinese patients with NSCLC in our center.

Method:

Retrospective medical data including demographic characteristics and referral information were collected for analysis. Overall survival (OS) was calculated as the time since cancer diagnosis till patient’s death. The time interval from palliative care (PC) referral to a patient’s death (PC-D) was calculated. The PC-D/OS ratio was calculated to illustrate the comparison of the duration of PC in the overall length of disease.

Results:

The mean age of 155 patients with advanced NSCLC was 62.83 years. Before referral to PC, 128 patients received anticancer treatment including surgeon (46.5%). Sixty-three (40.6%) patients died in palliative care unit. The median OS of 144 patients with end cutoff was 19 months (mean = 31.49, 95% confidence interval [CI] = 25.86-37.12). The median PC-D was 41 days (mean = 73.84, 95% CI = 60.37-87.40). The mean interval of PC-D/OS of 144 patients with definitely death time was 0.22 (SD: 0.27, 95% CI: 0.17-0.26). The median interval was 0.089. More than half of patients (n = 75, 51.8%) underwent PC less than 1% time (PC-D/OS < 0.1) of their whole disease course. Patients who were indigenous to Shanghai (P = .013) and who had brain metastasis (P = .072) had the potential longer PC-D/OS ratio. A high proportion of patients reported loss of appetite (92.8%) and fatigue (91.4%) at the initial of referral to PC.

Conclusion:

This retrospective study, in a population of patients with advanced NSCLC, gave detailed information about PC services in a tertiary cancer center.

Keywords

early palliative care advanced non-small cell lung cancer overall survival timing of referral symptom management predictors for early palliative care

Get full access to this article

View all access options for this article.

References

NCCN clinical practice guidelines in oncology: non-small cell lung cancer V. 2. 2017. www.nccn.org. Accessed November 15, 2017.

Chen

Zheng

Zhang

Zeng

. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27(1):2–12.

Jemal

Bray

Center

Ferlay

Ward

Forman

. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

Ettinger

Wood

Akerley

et al. NCCN guidelines insights: non-small cell lung cancer, version 4.2016. J Natl Compr Cancer Netw. 2016;14(3):255–264.

Temel

Greer

Muzikansky

et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–742.

Smith

Temin

Alesi

et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30(8):880–887.

Hui

Elsayem

et al. Availability and integration of palliative care at U.S. cancer centers. JAMA. 2010;303(11):1054–1061.

Vergnenègre

Hominal

Tchalla

et al. Assessment of palliative care for advanced non-small-cell lung cancer in France: a prospective observational multicenter study (GFPC 0804 study). Lung Cancer. 2013;82(2):353–357.

Reville

Miller

Toner

Reifsnyder

. End-of-life care for hospitalized patients with lung cancer: utilization of a palliative care service. J Palliat Med. 2010;13(10):1261–1266.

10.

Brickner

Scannell

Marquet

Ackerson

Barriers to hospice care and referrals: survey of physicians’ knowledge, attitudes, and perceptions in a health maintenance organization. J Palliat Med. 2004;7(3):411–418.

11.

Stillman

Syrjala

. Differences in physician access patterns to hospice care. J Pain Symptom Manage. 1999;17(3):157–163.

12.

Halkett

GKB

Jiwa

Meng

Leong

. Referring advanced cancer patients for palliative treatment: a national structured vignette survey of Australian GPs. Fam Pract. 2014;31(1):60–70.

13.

Duggan

Wiltshire

Strutt

et al. Palliative care and psychosocial care in metastatic non-small cell lung cancer: factors affecting utilisation of services and impact on patient survival. Support Care Cancer. 2019;27(3):911–919.

14.

Baek

Shin

Choi

et al. Late referral to palliative care services in Korea. J Pain Symptom Manage. 2011;41(4):692–699.

15.

Cheng

Chen

Liu

Zhang

. Timing of referral to inpatient palliative care services for advanced cancer patients and earlier referral predictors in mainland China. Palliat Supportive Care. 2016;14(5):503–509.

16.

Brule

Al-Baimani

Jonker

et al. Palliative systemic therapy for advanced non-small cell lung cancer: investigating disparities between patients who are treated versus those who are not. Lung Cancer. 2016;97:15–21.

17.

Ferrell

Temel

Temin

et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(1):96–112.

18.

Janssens

Teugels

Kohl

Michielsen

van Meerbeeck

. Integrating early palliative care (EPC) in the management of lung cancer: the role of the thoracic oncologist. Lung Cancer. 2015;90(2):135–138.

19.

Nieder

Tollåli

Haukland

Reigstad

Flatøy

Engljähringer

. Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer. Support Care Cancer. 2016;24(10):4385–4391.

20.

Hui

Kim

Roquemore

Dev

Chisholm

Bruera

. Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer. 2014;120(11):1743–1749.

21.

Otsuka

Koyama

Matsuoka

et al. Early palliative intervention for patients with advanced cancer. Jpn J Clin Oncol. 2013;43(8):788–794.

22.

Reyes-Gibby

Anderson

Shete

Bruera

Yennurajalingam

. Early referral to supportive care specialists for symptom burden in lung cancer patients. Cancer. 2012;118(3):856–863.

23.

Lorenzo

Modesto

Pérez

et al. Quality-of-life assessment in malignant pleural effusion treated with indwelling pleural catheter: a prospective study. Palliat Med. 2014;28(4):326–334.

24.

Psallidas

Yousuf

Talwar

et al. Assessment of patient-reported outcome measures in pleural interventions. BMJ Open Respir Res. 2017;4(1):e000171.

25.

Kastelik

. Management of malignant pleural effusion. Lung. 2013;191(2):165–175.

26.

Owen

Souhami

. The management of brain metastases in nonsmall cell lung cancer. Front Oncol. 2014;4:248.

27.

Dorman

Hayes

Pease

. What do patients with brain metastases from non-small cell lung cancer want from their treatment? Palliat Med. 2009;23(7):594–600.

28.

Peters

Bexelius

Munk

Leighl

. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer. Cancer Treat Rev. 2016;45:139–162.

29.

Cosgriff

Pisani

Bradley

O’Leary

Fried

. The association between treatment preferences and trajectories of care at the end of life. J Gen Intern Med. 2007;22(11):1566–1571.